Institutional investors purchased a net $4.0 million shares of OXGN during the quarter ended March 2015 and now own 24.53% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
EQUITEC SPECIALISTS LLC Bought 1.4 Million shares of OXiGENE Inc
FRIGATE VENTURES LP Bought 1.3 Million shares of OXiGENE Inc
SABBY CAPITAL LLC Bought 1.2 Million shares of OXiGENE Inc